People have cancer because of their sins, this is divine justice: BJP Health Minister

Agencies
November 23, 2017

Guwahati, Nov 23: BJP leader and Assam Health Minister Himanta Biswa Sarma has kicked up a storm with his remarks that some people suffer from life-threatening diseases such as cancer because of sins committed in the past which he called "divine justice".

The comments sparked sharp reactions in the political circles and among cancer patients. "God makes us suffer when we sin. Sometimes we come across young men getting inflicted with cancer or young men meeting with accidents. If you observe the background you will come to know that it's divine justice. Nothing else. We have to suffer that divine justice," Sarma said at a function organised for distribution of appointment letters to teachers here yesterday.

"In this lifetime or in our previous life, or perhaps my father or mother... perhaps that young man did not do but his father has done something wrong. It is mentioned even in Gita, Bible about the outcome of one's actions. No point in being sad... all will get the outcome of this life's actions in this life only. That divine justice always will be there. Nobody can escape the divine justice that will happen," he said.

Reacting to the comments, Congress leader Debabratta Saikia today said, "It is unfortunate that the health minister has made such a remark on cancer patients hurting their feelings. As he has made the remark publicly, the minister should also apologise for it publicly."

AIUDF leader Aminul Islam asserted that the health minister made this remark to cover his failure to control the spread of cancer in the state.

"He has given up, he can't control," he said.

Some cancer patients said they were saddened by the health minister's remarks at a time when it is an established medical fact that there are scientific reasons and various other parameters responsible for the disease.

State-run Dr B Barooah Cancer Institute's Medical Superintendent Dr B B Borthakur sought to downplay Sarma's remarks.

"I don't think the minister made the remark on scientific basis but in a social context as I understand. I don't think it is a matter to be made into a controversy. It is not a matter to be given so much importance," he told

Comments

Fairman
 - 
Thursday, 23 Nov 2017

-    Small innocent also get cancer. what crime did they commit.

 

-  He says further,  the sin might be committed by patient's parents.  

     ' The God is not stupid like BJP leaders.

       The God will never punish some one for sins committed by others.

 

-   The God might definitely punish these leaders and their supporters for hurting the sentimenst of

    these cancer patients.

 

- He says ' Geetha  and Bible says it'  

    I dont know about Geetha, but I know The Bible will not say it.  The Quran clearly says, the God will not punish some one for any crime committed by others.

 

No doubt very soon, note only intellectuals even common people will realize  BJP leaders and its voters.

 

 

This is the peak height of  shameless BJP leaders.

I dont know how to express  mentality of such leaders.

If a leader is such minded, what could be the level of lower levelled  voters.

 

Oh my friends,  do not bring such rottend minded men to distroy the country.

 

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 24,2020

New Delhi, June 24: The United Arab Emirates (UAE) has asked Air India to not carry any passengers aboard the repatriation flights to UAE being operated under the Vande Bharat Mission.

As per the Guidelines issued by the General Civil Aviation Authority of United Arab Emirates (UAE)- Safety Decision 2020-01 (Issue 17) Q and A Guidance For Foreign Operators, on June 23, 2020 - transportation of passengers ( UAE Nationals and Non - UAE Nationals) to the United Arab Emirates on the repatriation flights is not allowed.

In view of the foregoing, all passengers including the Indian Nationals who are holding valid Residency Permit / Work Permit of United Arab Emirates and have procured approval of the UAEs Federal Authority for Identity and Citizenship- UAE (ICA) of United Arab Emirates or an approval from the General Directorate of Residency and Foreigners Affairs (GDRFA) applicable to Dubai would need to have specific approval from the Embassy of the United Arab Emirates in New Delhi and their UAE Ministry of Foreign Affairs and International Cooperation (MOFAIC) to travel from India to United Arab Emirates (UAE) on these repatriation flights.

All passengers need to comply with the quarantine and COVID-19 test requirements as per the preventive and the precautionary measures required by the appropriate health authorities, as notified from time to time.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 11,2020

New Delhi, May 11: With an increase of 4,213 cases in the past 24 hours, India's COVID-19 count reached 67,152 on Monday, according to the Union Ministry of Health and Family Welfare.

The number of active cases in the country rose to 44,029, while 20,916 patients have been cured and discharged and one has migrated, according to the Ministry.

The number of deaths in the country due to the infection reached 2,206 on Sunday.

Maharashtra, with 22,171 confirmed cases is the worst-affected due to the infection so far and is followed by Gujarat with 8,194 cases.

However, Tamil Nadu surpassed the national capital in total coronavirus cases numbers. Delhi has 6,923 reported cases while Tamil Nadu has 7,204 confirmed cases.

Maximum deaths due to coronavirus have so far been recorded in Maharashtra (832), followed by Gujarat which has toll of 493.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.